| Literature DB >> 34635677 |
Mădălina Maria Nichitoi1, Ana Maria Josceanu2, Raluca Daniela Isopescu3, Gabriela Olimpia Isopencu4, Elisabeta-Irina Geana5, Corina Teodora Ciucure5, Vasile Lavric3.
Abstract
Propolis, a complex bee product, is a source of numerous bioactive principles, beneficial for human health, therefore it is intensively studied. In the present work, extracts of propolis from Bihor Romanian County were studied to identify the relationship between the polyphenolic derivatives profile and their antioxidant and antimicrobial activity. Extracts were obtained using water and 25%, 50%, and 70% ethanolic solutions (w/w), at 2:1, 4:1, and 6:1 liquid: solid ratios (w/w). 21 polyphenolic derivatives were quantified by UHPLC-MS, proving that the extracts composition strongly depends on the solvent. The sum of quantified polyphenolics extracted varied between 1.5 and 91.2 mg/g propolis. The antioxidant capacity was evaluated using the free radicals 2,2'-azino-bis (3-ethylbenzothiazoline-6 sulfonic acid) diammonium salt (ABTS) and 1-diphenyl-2-picryl-hydrazyl (DPPH) scavenging methods. Antimicrobial efficiency was tested against Gram-positive (B. subtilis), Gram-negative bacteria (E. coli), and fungi (C. albicans) by disc-diffusion method. All extracts, even the aqueous ones, demonstrated antibacterial and antifungal activity. Chemometric methods (partial least squares) and a saturation-type model were used to evaluate the contribution of various bioactive principles in building the antioxidant capacity of extracts. Both experimental and modelling results show that 50% ethanolic extracts provide a rich polyphenolics profile and ensure a good antioxidant capacity.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34635677 PMCID: PMC8505647 DOI: 10.1038/s41598-021-97130-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Total extracted polyphenolic acids and flavonoids expressed as (a) μg/mL and (b) μg/g propolis.
Figure 2Polyphenolic derivatives composition pattern at different liquid : solid ratios in 50% ethanol (EE25–full colour, EE45–diagonal stripes upward, and EE65–diagonal stripes downward).
Figure 3Antioxidant effects variation (ABTS assay) with phenolic acids (a) and flavonoids (b) distribution.
Figure 4Antioxidant capacity of the propolis extracts evaluated with the DPPH method.
Figure 5Model-experiment parity plots in various solvents: (a) water; (b) 25% ethanol; (c) 50% ethanol; (d) 70% ethanol.
Significant chemical compounds in the PLS regression vector.
| Solvent | Water extract | 25% ethanolic extract | 50% ethanolic extract | 70% ethanolic extract |
|---|---|---|---|---|
| Compounds with VIP scores > 1 | ferulic acid, caffeic acid, | caffeic acid, | caffeic acid, |
Figure 6Antioxidant capacity as function of samples total polyphenolic derivatives content.
The antimicrobial activity of propolis extracts.
| Extract | ||||||
|---|---|---|---|---|---|---|
| Inhibition zone, mm | MIC, μg/mL | Inhibition zone, mm | MIC, μg/mL | Inhibition zone, mm | MIC, μg/mL | |
| A21 | 0.50a | < 1663 | 1.00a | 4990 | 1.33 ± 0.47 | < 832 |
| A41 | 1.00a | 2.33 ± 0.94 | ||||
| A61 | 2.00a | 2.67 ± 0.47 | ||||
| A23 | 0.50a | < 832 | 0.67 ± 0.24 | 2495 | 1.00 ± 0.82 | < 832 |
| A43 | 1.00a | 0.50a | 2.00 ± 0.82 | |||
| A63 | 2.33 ± 0.47 | 1.33 ± 0.47 | ||||
| A25 | <832 | 0.50a | < 1633 | 2.01 | < 832 | |
| A45 | 1.00a | 0.50a | 2.00 ± 1.00 | |||
| A65 | 2.67 ± 0.47 | 0.508 | 2.67 ± 0.47 | |||
| E21 | 1610 | 1.67 ± 0.47 | < 805 | 1610 | ||
| E41 | 2.00a | |||||
| E61 | 1.33 ± 0.7 | 2.00a | 1.67 ± 0.47 | |||
| E23 | 1610 | 1.33 ± 0.47 | < 805 | na | 2415 | |
| E43 | 2.00a | 0.33 ± 0.12 | ||||
| E63 | 1.67 ± 0.47 | 2.67 ± 0.47 | ||||
| E25 | 1610 | 1208 | 1.00 ± 0.94 | 805 | ||
| E45 | 2.67 ± 0.47 | na | ||||
| E65 | 1.00a | 0.83 ± 0.5 | ||||
| EE21 | 1.00a | < 1537 | 2.00 | < 768.5 | 2305 | |
| EE41 | 1.00a | 4.67 ± 0.47 | 1.00a | |||
| EE61 | 1.33 ± 0.47 | 4.33 ± 0.47 | 1.00a | |||
| EE23 | 1.00 ± 0.41 | < 1537 | 3.67 ± 1.25 | < 769 | 0.67 ± 0.14 | 769 |
| EE43 | 1.00a | 1.67 ± 0.47 | 1.33 ± 0.47 | |||
| EE63 | 1.67 ± 0.47 | 2.33 ± 1.25 | 1.33 ± 0.47 | |||
| EE25 | < 769 | 2.33 ± 1.25 | < 76 | 1153 | ||
| EE45 | 2.00a | 4.00a | 1.67 ± 1.25 | |||
| EE65 | 1.33 ± 0.47 | 3.00 ± 0.82 | ||||
| EEE21 | 0.06a | < 1440 | 0.33 ± 0.27 | < 720 | 1440 | |
| EEE41 | 1.94 ± 0.63 | 2.78 ± 1.16 | ||||
| EEE61 | 1.61 ± 0.68 | 3.22 ± 0.16 | 0.33 ± 0.02 | |||
| EEE23 | < 720 | 2.00 ± 0.47 | < 720 | 1080 | ||
| EEE43 | 1.72 ± 0.72 | 4.67 ± 0.47 | 1.00 ± 0.16 | |||
| EEE63 | 3.39 ± 0.47 | 3.78 ± 0.42 | 1.22 ± 0.31 | |||
| EEE25 | 1080 | 1.56 ± 0.31 | < 720 | < 2160 | ||
| EEE45 | 1.50 ± 0.54 | 3.33 ± 0.98 | 0.89 ± 0.16 | |||
| EEE65 | 1.83 ± 0.57 | 2.22 ± 0.16 | 0.78 ± 0.16 | |||
na non active (no areas of inhibition reported).
aidentical replicates.
E. coli Escherichia coli.
B. subtilis Bacillus subtilis spizizenii nakamura.
C. albicans Candida albicans.